Search Login Register

Zanamivir (Relenza) Summary

Description: A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.

Also Known As: Relenza; 2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid; 2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid; 4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid; 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid Show All >>

Networked: 567 relevant articles (101 outcomes, 106 trials/studies) for this Drug

Key Diseases for which Zanamivir is Relevant

  1. Human Influenza (Influenza) : 89 outcomes 93 studies in 503 results
  2. Infection : 33 outcomes 18 studies in 129 results
  3. Influenza in Birds (Avian Flu) : 3 outcomes 3 studies in 22 results
  4. Pneumonia (Pneumonitis) : 2 outcomes 2 studies in 16 results
  5. Otitis Media : 2 outcomes in 3 results
Show All >>

Drugs Related to Zanamivir

  1. Oseltamivir (Tamiflu)
  2. Neuraminidase (Sialidase)
  3. Zanamivir (Relenza)
  4. Amantadine (Aman)
  5. Rimantadine
  6. Antiviral Agents (Antivirals)
  7. R 125489
  8. peramivir
  9. CS 8958
  10. 15- methyl- 8- aza- 16- oxagona- 1,3,5(10),13- tetraen- 17- one (MAOTO)
Show All >>

Therapies Related to Zanamivir

  1. Chemoprevention
  2. Home Nursing (Nursing, Home)
  3. Intranasal Administration
  4. Inhalation Administration
  5. Long-Term Care
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.